Optimizing Delivery and Endpoints of an AAV9-mediated Gene Therapy Trial in AMN
Awardee: Florian Eichler
Institution: Massachusetts General Hospital, Harvard Medical School
Award Amount: $50,000
Funding Period: January 1, 2016 - December 31, 2016
Previous
Previous
Development of next-gen animal models for fibrous dysplasia (FD)/McCune-Albright syndrome (MAS)
Next
Next